Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

KIT Signaling Governs Differential Sensitivity of Mature and Primitive CML Progenitors to Tyrosine Kinase Inhibitors

Corbin, AS and O'Hare, T and Gu, Z and Kraft, IL and Eiring, AM and Khorashad, JS and Pomicter, AD and Zhang, TY and Eide, CA and Manley, PW and Cortes, JE and Druker, BJ and Deininger, MW (2013) KIT Signaling Governs Differential Sensitivity of Mature and Primitive CML Progenitors to Tyrosine Kinase Inhibitors. CANCER RESEARCH. pp. 5775-5786.

Item Type: Article
Additional Information: pubid: 131 nvp_institute: NIBR contributor_address: Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA, Howard Hughes Med Inst, Chevy Chase, MD USA ; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA, Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA michael.deininger@hci.utah.edu; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA ; Novartis Inst BioMed Res, Basel, Switzerland ; Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA ; Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA; Howard Hughes Med Inst, Chevy Chase, MD USA; Deininger, M W; Univ Utah, Huntsman Canc Inst, 2000 Circle Hope,Room 4280, Salt Lake City, UT 84112 USA
Date Deposited: 13 Oct 2015 13:12
Last Modified: 13 Oct 2015 13:12
URI: https://oak.novartis.com/id/eprint/21966

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.